Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |